Matches in SemOpenAlex for { <https://semopenalex.org/work/W2496277056> ?p ?o ?g. }
- W2496277056 endingPage "56308" @default.
- W2496277056 startingPage "56295" @default.
- W2496277056 abstract "Around, 30-40% of HER2-positive breast cancers do not show substantial clinical benefit from the targeted therapy and, thus, the mechanisms underlying resistance remain partially unknown. Interestingly, ERBB2 is frequently co-amplified and co-expressed with neighbour genes that may play a relevant role in this cancer subtype. Here, using an in silico analysis of data from 2,096 breast tumours, we reveal a significant correlation between Gasdermin B (GSDMB) gene (located 175 kilo bases distal from ERBB2) expression and the pathological and clinical parameters of poor prognosis in HER2-positive breast cancer. Next, the analysis of three independent cohorts (totalizing 286 tumours) showed that approximately 65% of the HER2-positive cases have GSDMB gene amplification and protein over-expression. Moreover, GSDMB expression was also linked to poor therapeutic responses in terms of lower relapse free survival and pathologic complete response as well as positive lymph node status and the development of distant metastasis under neoadjuvant and adjuvant treatment settings, respectively. Importantly, GSDMB expression promotes survival to trastuzumab in different HER2-positive breast carcinoma cells, and is associated with trastuzumab resistance phenotype in vivo in Patient Derived Xenografts. In summary, our data identifies the ERBB2 co-amplified and co-expressed gene GSDMB as a critical determinant of poor prognosis and therapeutic response in HER2-positive breast cancer." @default.
- W2496277056 created "2016-08-23" @default.
- W2496277056 creator A5007606531 @default.
- W2496277056 creator A5014248500 @default.
- W2496277056 creator A5017466693 @default.
- W2496277056 creator A5024097289 @default.
- W2496277056 creator A5028384284 @default.
- W2496277056 creator A5029357711 @default.
- W2496277056 creator A5033987639 @default.
- W2496277056 creator A5034914676 @default.
- W2496277056 creator A5043055023 @default.
- W2496277056 creator A5043548968 @default.
- W2496277056 creator A5045516558 @default.
- W2496277056 creator A5052379741 @default.
- W2496277056 creator A5058485099 @default.
- W2496277056 creator A5064332999 @default.
- W2496277056 creator A5067861199 @default.
- W2496277056 creator A5075698989 @default.
- W2496277056 creator A5077169627 @default.
- W2496277056 creator A5081259888 @default.
- W2496277056 creator A5081288223 @default.
- W2496277056 creator A5090159813 @default.
- W2496277056 creator A5090303240 @default.
- W2496277056 date "2016-07-22" @default.
- W2496277056 modified "2023-10-18" @default.
- W2496277056 title "Gasdermin B expression predicts poor clinical outcome in HER2-positive breast cancer" @default.
- W2496277056 cites W1550684847 @default.
- W2496277056 cites W1587045552 @default.
- W2496277056 cites W1864325817 @default.
- W2496277056 cites W1882905539 @default.
- W2496277056 cites W1966163828 @default.
- W2496277056 cites W1972635337 @default.
- W2496277056 cites W1983380290 @default.
- W2496277056 cites W1983716676 @default.
- W2496277056 cites W1986896902 @default.
- W2496277056 cites W1994135074 @default.
- W2496277056 cites W1994655768 @default.
- W2496277056 cites W1996778928 @default.
- W2496277056 cites W1998032903 @default.
- W2496277056 cites W1999919183 @default.
- W2496277056 cites W2004630776 @default.
- W2496277056 cites W2023662215 @default.
- W2496277056 cites W2040098015 @default.
- W2496277056 cites W2044702943 @default.
- W2496277056 cites W2045413188 @default.
- W2496277056 cites W2054711461 @default.
- W2496277056 cites W2067527491 @default.
- W2496277056 cites W2070083767 @default.
- W2496277056 cites W2073009876 @default.
- W2496277056 cites W2077706404 @default.
- W2496277056 cites W2086080480 @default.
- W2496277056 cites W2086486491 @default.
- W2496277056 cites W2087638216 @default.
- W2496277056 cites W2096283457 @default.
- W2496277056 cites W2098775844 @default.
- W2496277056 cites W2098942227 @default.
- W2496277056 cites W2106714771 @default.
- W2496277056 cites W2113165452 @default.
- W2496277056 cites W2113506041 @default.
- W2496277056 cites W2113839377 @default.
- W2496277056 cites W2120661754 @default.
- W2496277056 cites W2125401809 @default.
- W2496277056 cites W2125511612 @default.
- W2496277056 cites W2125620887 @default.
- W2496277056 cites W2127433418 @default.
- W2496277056 cites W2132285133 @default.
- W2496277056 cites W2136404962 @default.
- W2496277056 cites W2141546964 @default.
- W2496277056 cites W2148752410 @default.
- W2496277056 cites W2151262170 @default.
- W2496277056 cites W2155560234 @default.
- W2496277056 cites W2156677665 @default.
- W2496277056 cites W2158794266 @default.
- W2496277056 cites W2159967578 @default.
- W2496277056 cites W2167341447 @default.
- W2496277056 cites W2175794645 @default.
- W2496277056 cites W2288763477 @default.
- W2496277056 cites W2318605753 @default.
- W2496277056 cites W2560367415 @default.
- W2496277056 cites W628007497 @default.
- W2496277056 doi "https://doi.org/10.18632/oncotarget.10787" @default.
- W2496277056 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5302915" @default.
- W2496277056 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27462779" @default.
- W2496277056 hasPublicationYear "2016" @default.
- W2496277056 type Work @default.
- W2496277056 sameAs 2496277056 @default.
- W2496277056 citedByCount "78" @default.
- W2496277056 countsByYear W24962770562017 @default.
- W2496277056 countsByYear W24962770562018 @default.
- W2496277056 countsByYear W24962770562019 @default.
- W2496277056 countsByYear W24962770562020 @default.
- W2496277056 countsByYear W24962770562021 @default.
- W2496277056 countsByYear W24962770562022 @default.
- W2496277056 countsByYear W24962770562023 @default.
- W2496277056 crossrefType "journal-article" @default.
- W2496277056 hasAuthorship W2496277056A5007606531 @default.
- W2496277056 hasAuthorship W2496277056A5014248500 @default.
- W2496277056 hasAuthorship W2496277056A5017466693 @default.